Cargando…
A Single 60 mg Dose of Denosumab Might Improve Hepatic Insulin Sensitivity in Postmenopausal Nondiabetic Severe Osteoporotic Women
Background. The RANKL/RANK/OPG signaling pathway is crucial for the regulation of osteoclast activity and bone resorption being activated in osteoporosis. The pathway has been also suggested to influence glucose metabolism as observed in chronic low inflammation. Aim. To test whether systemic blocka...
Autores principales: | Passeri, Elena, Benedini, Stefano, Costa, Elena, Corbetta, Sabrina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4383275/ https://www.ncbi.nlm.nih.gov/pubmed/25873952 http://dx.doi.org/10.1155/2015/352858 |
Ejemplares similares
-
Effect of Denosumab on Glucose Homeostasis in Postmenopausal Women with Breast Cancer Treated with Aromatase Inhibitors: A Pilot Study
por: Rossini, Alessandro, et al.
Publicado: (2020) -
Autoimmune Polyendocrine Syndrome 3 Onset with Severe Ketoacidosis in a 74-Year-Old Woman
por: Benedini, Stefano, et al.
Publicado: (2015) -
Effect of low dose denosumab on bone mineral density in postmenopausal women with osteoporosis after a transition from 60 mg dose: a prospective observational study
por: Khan, Aliya A., et al.
Publicado: (2023) -
Hypertryptasemia and Mast Cell-Related Disorders in Severe Osteoporotic Patients
por: Carosi, Giulia, et al.
Publicado: (2020) -
Efficacy of Low Dose Denosumab in Maintaining Bone Mineral Density in Postmenopausal Women With Osteoporosis Switching From 60mg to 30mg 6 Monthly: A Real World, Prospective Observational Study
por: Khan, Aliya, et al.
Publicado: (2021)